Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mario Fernández-Ruiz & José María Aguado. (2018) Risk of infection associated with anti-TNF-α therapy. Expert Review of Anti-infective Therapy 16:12, pages 939-956.
Read now
Read now
Bettina Butzke, Fuat S. Oduncu, Franziska Severin, Arne Pfeufer, Volker Heinemann, Clemens Giessen-Jung, Björn Stollenwerk & Wolf H. Rogowski. (2016) The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance. Acta Oncologica 55:3, pages 318-328.
Read now
Read now
Ali Keshavarzian, Ashkan Farhadi & Ece A Mutlu. (2002) New developments in the treatment of inflammatory bowel disease. Expert Opinion on Investigational Drugs 11:3, pages 365-385.
Read now
Read now
Helena Linardou & Samuel Murray. (2002) Non-cancer therapeutic antibodies. Expert Opinion on Therapeutic Patents 12:3, pages 401-417.
Read now
Read now
Articles from other publishers (16)
Dong W. Kim, Yousun Lee, Geuntae Kim, Sang H. Kim, Dae H. Cho, Jeongmin Choi, Yong H. Kwon, Younjin Park, Wooree Choi & Dong I. Park. (2023) Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea. Advances in Therapy 40:3, pages 1047-1061.
Crossref
Crossref
P. K. Shukla, Pratiksha Singh, Ravindra Kumar Yadav, Smriti Pandey & Shome S. Bhunia. 2018. Communicable Diseases of the Developing World. Communicable Diseases of the Developing World
125
167
.
Amitava Das, Scott Chaffee & Sashwati Roy. 2015. Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods. Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods
61
70
.
Ben Wielockx, Jan Staelens, Leen Puimège, Ineke Vanlaere, Maarten Van Roy, Philippe van Lint, Frans Van Roy & Claude Libert. (2007) Description and Mapping of the Resistance of DBA/2 Mice to TNF-Induced Lethal Shock. The Journal of Immunology 178:8, pages 5069-5075.
Crossref
Crossref
Faten N. Aberra & Gary R. Lichtenstein. (2006) Infliximab in Ulcerative Colitis. Gastroenterology Clinics of North America 35:4, pages 821-836.
Crossref
Crossref
Sashwati RoySavita KhannaAlluri V. KrishnarajuGottumukkala V. SubbarajuTaharat YasminDebasis BagchiChandan K. Sen. (2006)
Regulation of Vascular Responses to Inflammation: Inducible Matrix Metalloproteinase-3 Expression in Human Microvascular Endothelial Cells Is Sensitive to Antiinflammatory
Boswellia
. Antioxidants & Redox Signaling 8:3-4, pages 653-660.
Crossref
Crossref
Sashwati RoySavita KhannaHiral ShahCameron RinkChristina PhillipsHarry PreussGottumukkala V. SubbarajuGolakoti TrimurtuluAlluri V. KrishnarajuManashi BagchiDebasis BagchiChandan K. Sen. (2005)
Human Genome Screen to Identify the Genetic Basis of the Anti-inflammatory Effects of
Boswellia
in Microvascular Endothelial Cells
. DNA and Cell Biology 24:4, pages 244-255.
Crossref
Crossref
Shamina Dhillon & Edward V. LoftusJrJr. (2005) Medical therapy of Crohn’s disease. Current Treatment Options in Gastroenterology 8:1, pages 19-30.
Crossref
Crossref
Lawrence W Comerford & Stephen J Bickston. (2004) Treatment of luminal and fistulizing Crohn's disease with infliximab. Gastroenterology Clinics of North America 33:2, pages 387-406.
Crossref
Crossref
Trent M. Woodruff, Thiruma V. Arumugam, Ian A. Shiels, Robert C. Reid, David P. Fairlie & Stephen M. Taylor. (2003) A Potent Human C5a Receptor Antagonist Protects against Disease Pathology in a Rat Model of Inflammatory Bowel Disease. The Journal of Immunology 171:10, pages 5514-5520.
Crossref
Crossref
Howard B. Cottam. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Mi-Jung Yeom, Han-Chang Lee, Gun-Ho Kim, Insop Shim, Hye-Jung Lee & Dae-Hyun Hahm. (2003) Therapeutic Effects of <i>Hominis placenta</i> Injection into an Acupuncture Point on the Inflammatory Responses in Subchondral Bone Region of Adjuvant-Induced Polyarthritic Rat. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 26:10, pages 1472-1477.
Crossref
Crossref
Paul S Aisen. (2002) The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. The Lancet Neurology 1:5, pages 279-284.
Crossref
Crossref
Roly Foulkes. (2002) Preclinical safety evaluation of monoclonal antibodies. Toxicology 174:1, pages 21-26.
Crossref
Crossref
Robert W. McMurray. (2002) A New Century of Antirheumatic Therapy. The American Journal of the Medical Sciences 323:4, pages 169-170.
Crossref
Crossref
Yin Bai, Yan Wang, Li-Jun Zhou & Li-Zhang Yu. (2001) Construction and expression of a human-mouse chimeric antibody against human bladder cancer. Chinese Journal of Cancer Research 13:4, pages 271-275.
Crossref
Crossref